Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 12;13(11):1913.
doi: 10.3390/pharmaceutics13111913.

Advances in the Application of Nanomaterials as Treatments for Bacterial Infectious Diseases

Affiliations
Review

Advances in the Application of Nanomaterials as Treatments for Bacterial Infectious Diseases

Yuan-Pin Hung et al. Pharmaceutics. .

Abstract

Bacteria-targeting nanomaterials have been widely used in the diagnosis and treatment of bacterial infectious diseases. These nanomaterials show great potential as antimicrobial agents due to their broad-spectrum antibacterial capacity and relatively low toxicity. Recently, nanomaterials have improved the accurate detection of pathogens, provided therapeutic strategies against nosocomial infections and facilitated the delivery of antigenic protein vaccines that induce humoral and cellular immunity. Biomaterial implants, which have traditionally been hindered by bacterial colonization, benefit from their ability to prevent bacteria from forming biofilms and spreading into adjacent tissues. Wound repair is improving in terms of both the function and prevention of bacterial infection, as we tailor nanomaterials to their needs, select encapsulation methods and materials, incorporate activation systems and add immune-activating adjuvants. Recent years have produced numerous advances in their antibacterial applications, but even further expansion in the diagnosis and treatment of infectious diseases is expected in the future.

Keywords: bacterial infection; biofilms; implants; nanoparticle; polymers; silver nanoparticle.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

Figures

Figure 1
Figure 1
Schematic illustration of TRAIL encapsulated in bactericidal polypeptide nanogels, adapted from [36], published by Elsevier, 2019.
Figure 2
Figure 2
Schematic illustration of the antibacterial mechanism of star-shaped graft copolypeptides, adapted from [36], published by Elsevier, 2019.
Figure 3
Figure 3
Advances in the use of NPs to treat bacterial infectious diseases in different body systems.

References

    1. Duval R.E., Grare M., Demore B. Fight against Antimicrobial Resistance: We Always Need New Antibacterials but for Right Bacteria. Molecules. 2019;24:3152. doi: 10.3390/molecules24173152. - DOI - PMC - PubMed
    1. Penesyan A., Gillings M., Paulsen I.T. Antibiotic discovery: Combatting bacterial resistance in cells and in biofilm communities. Molecules. 2015;20:5286–5298. doi: 10.3390/molecules20045286. - DOI - PMC - PubMed
    1. Aguilera-Correa J.J., Esteban J., Vallet-Regi M. Inorganic and Polymeric Nanoparticles for Human Viral and Bacterial Infections Prevention and Treatment. Nanomaterials. 2021;11:137. doi: 10.3390/nano11010137. - DOI - PMC - PubMed
    1. Lyu Y., Yu M., Liu Q., Zhang Q., Liu Z., Tian Y., Li D., Changdao M. Synthesis of silver nanoparticles using oxidized amylose and combination with curcumin for enhanced antibacterial activity. Carbohydr. Polym. 2020;230:115573. doi: 10.1016/j.carbpol.2019.115573. - DOI - PubMed
    1. Nag S., Biswas A., Chattopadhyay D., Bhattacharyya M. Protein-stabilized silver nanoparticles encapsulating gentamycin for the therapy of bacterial biofilm infections. Nanomedicine. 2021;16:801–818. doi: 10.2217/nnm-2020-0451. - DOI - PubMed

LinkOut - more resources